1. Home
  2. SRPT vs AFYA Comparison

SRPT vs AFYA Comparison

Compare SRPT & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • AFYA
  • Stock Information
  • Founded
  • SRPT 1980
  • AFYA 1999
  • Country
  • SRPT United States
  • AFYA Brazil
  • Employees
  • SRPT N/A
  • AFYA N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • SRPT Health Care
  • AFYA Real Estate
  • Exchange
  • SRPT Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • SRPT 1.7B
  • AFYA 1.6B
  • IPO Year
  • SRPT 1997
  • AFYA 2019
  • Fundamental
  • Price
  • SRPT $11.93
  • AFYA $14.47
  • Analyst Decision
  • SRPT Hold
  • AFYA Sell
  • Analyst Count
  • SRPT 28
  • AFYA 5
  • Target Price
  • SRPT $48.42
  • AFYA $17.60
  • AVG Volume (30 Days)
  • SRPT 13.9M
  • AFYA 89.4K
  • Earning Date
  • SRPT 08-06-2025
  • AFYA 08-15-2025
  • Dividend Yield
  • SRPT N/A
  • AFYA 1.60%
  • EPS Growth
  • SRPT N/A
  • AFYA 41.32
  • EPS
  • SRPT N/A
  • AFYA 1.31
  • Revenue
  • SRPT $2,233,371,000.00
  • AFYA $599,363,389.00
  • Revenue This Year
  • SRPT $19.93
  • AFYA $15.55
  • Revenue Next Year
  • SRPT N/A
  • AFYA $8.70
  • P/E Ratio
  • SRPT N/A
  • AFYA $11.05
  • Revenue Growth
  • SRPT 59.15
  • AFYA 15.70
  • 52 Week Low
  • SRPT $10.42
  • AFYA $14.41
  • 52 Week High
  • SRPT $150.48
  • AFYA $19.90
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 28.15
  • AFYA 19.28
  • Support Level
  • SRPT $10.42
  • AFYA $14.77
  • Resistance Level
  • SRPT $14.54
  • AFYA $15.32
  • Average True Range (ATR)
  • SRPT 1.90
  • AFYA 0.46
  • MACD
  • SRPT 0.13
  • AFYA -0.09
  • Stochastic Oscillator
  • SRPT 12.14
  • AFYA 1.39

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: